- Home
- TMDX vs SEM Comparison
TMDX vs SEM Comparison
Compare TMDX & SEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- SEM
- Stock Information
- Founded
- TMDX 1998
- SEM 1996
- Country
- TMDX United States
- SEM United States
- Employees
- TMDX N/A
- SEM N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SEM Hospital/Nursing Management
- Sector
- TMDX Health Care
- SEM Health Care
- Exchange
- TMDX Nasdaq
- SEM Nasdaq
- Market Cap
- TMDX 2.4B
- SEM 2.4B
- IPO Year
- TMDX 2019
- SEM 2009
- Fundamental
- Price
- TMDX $71.95
- SEM $17.64
- Analyst Decision
- TMDX Buy
- SEM Buy
- Analyst Count
- TMDX 11
- SEM 4
- Target Price
- TMDX $116.10
- SEM $36.67
- AVG Volume (30 Days)
- TMDX 1.3M
- SEM 836.1K
- Earning Date
- TMDX 02-27-2025
- SEM 02-20-2025
- Dividend Yield
- TMDX N/A
- SEM 2.49%
- EPS Growth
- TMDX N/A
- SEM N/A
- EPS
- TMDX 0.94
- SEM 1.23
- Revenue
- TMDX $401,090,000.00
- SEM $4,609,179,000.00
- Revenue This Year
- TMDX $81.61
- SEM N/A
- Revenue Next Year
- TMDX $22.52
- SEM N/A
- P/E Ratio
- TMDX $76.78
- SEM $14.37
- Revenue Growth
- TMDX 109.09
- SEM N/A
- 52 Week Low
- TMDX $55.00
- SEM $14.14
- 52 Week High
- TMDX $177.37
- SEM $22.08
- Technical
- Relative Strength Index (RSI)
- TMDX 52.52
- SEM 35.63
- Support Level
- TMDX $66.81
- SEM $18.21
- Resistance Level
- TMDX $80.00
- SEM $19.54
- Average True Range (ATR)
- TMDX 4.14
- SEM 0.68
- MACD
- TMDX 0.57
- SEM -0.13
- Stochastic Oscillator
- TMDX 48.74
- SEM 34.40
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About SEM Select Medical Holdings Corporation
Select Medical Holdings Corp is a healthcare company that operates through four main segments: critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and Concentra institutions. Critical illness recovery hospitals and rehabilitation centres are designed for patients requiring extended recovery time with medical services. These two sectors combined compose roughly half of the total revenue and include over 103 critical illness recovery hospitals and inpatient rehab facilities. The outpatient rehabilitation segment includes over 1,928 rehabilitation clinics. The Concentra segment includes over 540 occupational health centers and 147 onsite clinics. The company is headquartered in Pennsylvania, and it operates across the United States.